Budget Impact Analysis of Bevacizumab and Anti-Egfr with Chemotherapy for First and Second Line Treatment of Metastatic Colorectal Cancer in Russian Federation

May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.437
https://www.valueinhealthjournal.com/article/S1098-3015(14)00488-4/fulltext
Section Title : Cancer
Section Order : 1484
First Page : A75
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00488-4&doi=10.1016/j.jval.2014.03.437
HEOR Topics :
Tags :
Regions :